Fuan Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 166 million yuan, a decrease of 44.87%Zhitong·Oct 27, 2025 at 03:56 AM300194+0.82%
Fuan Pharmaceutical Announcement on the Implementation of the 2025 Half-Year Equity Distribution PlanZhitong·Sep 17, 2025 at 03:31 AM300194+0.82%
Fuan Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 113 million yuan, a decrease of 47.74%Zhitong·Aug 26, 2025 at 09:21 AM300194+0.82%
Asian Market Highlights: Penny Stocks To Watch In August 2025Simplywall·Aug 15, 2025 at 12:15 AM006910.00%300194+0.82%
The chemical pharmaceutical sector sees a short-term surge, with Fuan Pharmaceutical rising over 10%Zhitong·Aug 11, 2025 at 08:33 PM300194+0.82%
Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limitZhitong·Aug 11, 2025 at 08:32 PM000990-0.77%300194+0.82%
Fuan Pharmaceutical: The registration of injectable adenosine dimethylsulfonate has been completedZhitong·Jul 28, 2025 at 03:07 AM300194+0.82%
CITIC Securities: The trend of policy optimization such as centralized procurement is strengthening in certainty, and the pharmaceutical sector is expected to steadily rise in the second half of the yearZhitong·Jul 24, 2025 at 07:56 PM600196+0.26%02196-0.30%
Fuan Pharmaceutical's subsidiary has received the drug registration certificate for Alpha-Lipoic Acid TabletsZhitong·Jul 21, 2025 at 03:55 AM300194+0.82%
Fuan Pharmaceutical issued a profit warning, expecting a net profit attributable to the parent company of 100 million to 130 million yuan in the first half of the year, a year-on-year decrease of 39.95% to 53.81%Zhitong·Jul 18, 2025 at 03:54 AM300194+0.82%
Fuan Pharmaceutical: Adenosylcobalamin capsules have obtained a drug registration certificateZhitong·Jul 1, 2025 at 02:58 AM300194+0.82%
Fuan Pharmaceutical received the drug registration certificate for "Injectable Benzylpenicillin Sodium"Zhitong·Jun 10, 2025 at 03:19 AM300194+0.82%
Fuan Pharmaceutical: Currently, the business is mainly focused on the domestic market and has not been significantly affected by tariff fluctuationsZhitong·May 11, 2025 at 07:48 PM300194+0.82%
Fuan Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 280 million yuan, a year-on-year increase of 20.69%Zhitong·Apr 23, 2025 at 08:30 AM300194+0.82%
Fuan Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 69.049 million yuan, a year-on-year decrease of 43.63%Zhitong·Apr 23, 2025 at 08:28 AM300194+0.82%
